Sabra Financial Statements From 2010 to 2024

SBRA Stock  USD 13.78  0.12  0.88%   
Sabra Healthcare financial statements provide useful quarterly and yearly information to potential Sabra Healthcare REIT investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Sabra Healthcare financial statements helps investors assess Sabra Healthcare's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Sabra Healthcare's valuation are summarized below:
Gross Profit
372.8 M
Profit Margin
0.0213
Market Capitalization
3.2 B
Enterprise Value Revenue
8.5799
Revenue
644.6 M
We have found one hundred twenty available fundamental trend indicators for Sabra Healthcare REIT, which can be analyzed and compared to other ratios and to its competition. All investors should make sure to double-check all of Sabra Healthcare REIT current market performance against the performance between 2010 and 2024 to make sure the company can sustain itself down the road. The current year's Market Cap is expected to grow to about 3.5 B, whereas Enterprise Value is forecasted to decline to about 3.2 B.

Sabra Healthcare Total Revenue

404.91 Million

Check Sabra Healthcare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sabra main balance sheet or income statement drivers, such as Depreciation And Amortization of 116.9 M, Interest Expense of 84.9 M or Selling General Administrative of 29.5 M, as well as many exotic indicators such as Price To Sales Ratio of 10.02, Dividend Yield of 0.0653 or PTB Ratio of 1.53. Sabra financial statements analysis is a perfect complement when working with Sabra Healthcare Valuation or Volatility modules.
  
This module can also supplement Sabra Healthcare's financial leverage analysis and stock options assessment as well as various Sabra Healthcare Technical models . Check out the analysis of Sabra Healthcare Correlation against competitors.

Sabra Healthcare Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets4.2 B5.4 B3.8 B
Slightly volatile
Short and Long Term Debt Total1.9 B2.4 B1.8 B
Slightly volatile
Total Current Liabilities243 M231.4 M98.4 M
Slightly volatile
Total Stockholder Equity2.1 B2.8 B1.9 B
Slightly volatile
Other Liabilities47.8 M40.4 M50.8 M
Pretty Stable
Property Plant And Equipment Net3.3 B4.6 B1.6 B
Slightly volatile
Net Debt1.9 B2.4 B1.7 B
Slightly volatile
Accounts Payable171.8 M163.6 M82.5 M
Slightly volatile
Cash87 M46.7 M79.7 M
Very volatile
Non Current Assets Total3.8 B4.8 B3.4 B
Slightly volatile
Other Assets5.4 B5.2 B1.5 B
Slightly volatile
Long Term Debt2.4 B2.3 B944.7 M
Slightly volatile
Cash And Short Term Investments87 M46.7 M79.7 M
Very volatile
Common Stock Total Equity2.8 M2.7 M1.4 M
Slightly volatile
Common Stock Shares Outstanding131.1 M232.8 M120 M
Slightly volatile
Short Term Investments496.8 M473.1 M182.5 M
Slightly volatile
Liabilities And Stockholders Equity4.2 B5.4 B3.8 B
Slightly volatile
Non Current Liabilities Total1.9 B2.4 B1.8 B
Slightly volatile
Other Stockholder Equity2.7 B4.5 B2.4 B
Slightly volatile
Total LiabilitiesB2.6 B1.9 B
Slightly volatile
Property Plant And Equipment Gross627.4 M757.1 M651.2 M
Slightly volatile
Total Current Assets413.9 M543.3 M378.8 M
Slightly volatile
Common Stock1.4 M2.3 M1.3 M
Slightly volatile
Intangible Assets59.5 M30.9 M51.1 M
Slightly volatile
Net Tangible Assets2.4 B3.5 BB
Slightly volatile
Net Receivables323 M496.6 M258 M
Slightly volatile
Long Term Debt Total2.8 B2.7 BB
Slightly volatile
Capital Surpluse2.9 B5.2 B2.5 B
Slightly volatile
Short Term Debt186.8 M196.6 M685.6 M
Slightly volatile
Long Term Investments166.6 M194.7 M116.5 M
Slightly volatile
Short and Long Term Debt89.7 M94.4 M840.8 M
Slightly volatile
Capital Lease Obligations67.1 M63 M85.2 M
Slightly volatile
Net Invested Capital4.7 B5.2 B6.3 B
Slightly volatile
Non Current Liabilities Other49.6 M32.5 M78 M
Slightly volatile
Net Working Capital251.6 M311.9 M499.4 M
Slightly volatile
Capital Stock2.4 M2.3 MM
Slightly volatile

Sabra Healthcare Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization116.9 M183.1 M107 M
Slightly volatile
Selling General Administrative29.5 M47.5 M27 M
Slightly volatile
Total Revenue404.9 M655.8 M370.6 M
Slightly volatile
Gross Profit326.2 M277.5 M298.5 M
Slightly volatile
Other Operating Expenses216.3 M420.8 M197.9 M
Slightly volatile
Operating Income164.3 M235.1 M150.4 M
Slightly volatile
EBIT165.8 M235.1 M151.7 M
Slightly volatile
EBITDA282.7 M418.2 M258.7 M
Slightly volatile
Total Operating Expenses40.3 M42.4 M119.7 M
Slightly volatile
Cost Of Revenue397.2 M378.3 M101.2 M
Slightly volatile
Net Income From Continuing Ops13.1 M13.8 M82.7 M
Very volatile
Preferred Stock And Other Adjustments10.8 M11.2 M9.6 M
Slightly volatile
Tax Provision1.8 MM1.3 M
Slightly volatile
Reconciled Depreciation191.7 M183.1 M146.8 M
Slightly volatile
Interest Income6.7 M7.8 MM
Slightly volatile

Sabra Healthcare Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based CompensationM7.9 M7.3 M
Slightly volatile
Depreciation116.9 M183.1 M107 M
Slightly volatile
Total Cash From Operating Activities215.7 M301.1 M197.4 M
Slightly volatile
End Period Cash Flow89.7 M46.7 M82.1 M
Pretty Stable
Begin Period Cash Flow98.5 M53.9 M89.1 M
Pretty Stable
Dividends Paid202.1 M277.4 M174.8 M
Slightly volatile
Other Cashflows From Investing Activities110.2 M105.7 M96.5 M
Slightly volatile
Issuance Of Capital Stock247 M277.8 M302.5 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio10.025.03069.1751
Slightly volatile
Dividend Yield0.06530.08410.0808
Pretty Stable
PTB Ratio1.531.17721.3969
Slightly volatile
Days Sales Outstanding303276246
Pretty Stable
Book Value Per Share12.4512.121515.356
Pretty Stable
Invested Capital1.610.86141.4704
Slightly volatile
Operating Cash Flow Per Share1.31.30241.5997
Pretty Stable
Stock Based Compensation To Revenue0.01150.01210.03
Slightly volatile
PB Ratio1.531.17721.3969
Slightly volatile
EV To Sales8.268.689815.5616
Slightly volatile
Inventory Turnover8.58.0982.5551
Slightly volatile
Days Of Inventory On Hand42.8245.0727234
Pretty Stable
Payables Turnover1.081.030.5163
Slightly volatile
Sales General And Administrative To Revenue0.110.07240.1009
Slightly volatile
Average Inventory64.6 M86.3 M70.9 M
Slightly volatile
Cash Per Share0.190.20211.0402
Pretty Stable
POCF Ratio17.0210.956915.5779
Slightly volatile
Interest Coverage2.121.74891.9101
Very volatile
Days Payables Outstanding3493671.8 K
Slightly volatile
EV To Operating Cash Flow30.5618.926927.9626
Slightly volatile
Intangibles To Total Assets0.00550.00570.0178
Slightly volatile
Net Debt To EBITDA5.455.739312.3854
Slightly volatile
Current Ratio2.232.34784.9813
Pretty Stable
Tangible Book Value Per Share12.2411.987915.0921
Pretty Stable
Receivables Turnover2.341.32073.0033
Slightly volatile
Graham Number3.834.028314.9044
Pretty Stable
Shareholders Equity Per Share12.4512.121515.356
Pretty Stable
Debt To Equity1.610.86141.4704
Slightly volatile
Revenue Per Share2.472.83673.0465
Pretty Stable
Interest Debt Per Share10.4711.022822.3032
Pretty Stable
Debt To Assets0.720.44820.6568
Pretty Stable
Enterprise Value Over EBITDA12.9513.629429.197
Slightly volatile
Short Term Coverage Ratios1.611.53130.4594
Slightly volatile
Operating Cycle355321453
Very volatile
Price Book Value Ratio1.531.17721.3969
Slightly volatile
Days Of Payables Outstanding3493671.8 K
Slightly volatile
Price To Operating Cash Flows Ratio17.0210.956915.5779
Slightly volatile
Operating Profit Margin0.470.35840.4363
Pretty Stable
Company Equity Multiplier2.451.92192.2449
Slightly volatile
Long Term Debt To Capitalization0.570.44170.5214
Slightly volatile
Total Debt To Capitalization0.640.46280.5854
Slightly volatile
Return On Capital Employed0.04960.04560.0454
Pretty Stable
Debt Equity Ratio1.610.86141.4704
Slightly volatile
Ebit Per Revenue0.470.35840.4363
Pretty Stable
Quick Ratio3.462.34784.2634
Very volatile
Net Income Per E B T1.671.75443.4857
Slightly volatile
Cash Ratio0.190.20190.9597
Pretty Stable
Operating Cash Flow Sales Ratio0.590.45910.5452
Pretty Stable
Days Of Inventory Outstanding42.8245.0727234
Pretty Stable
Days Of Sales Outstanding303276246
Pretty Stable
Cash Flow Coverage Ratios0.06560.12470.0809
Slightly volatile
Price To Book Ratio1.531.17721.3969
Slightly volatile
Fixed Asset Turnover0.130.141738.0002
Slightly volatile
Price Cash Flow Ratio17.0210.956915.5779
Slightly volatile
Enterprise Value Multiple12.9513.629429.197
Slightly volatile
Debt Ratio0.720.44820.6568
Pretty Stable
Cash Flow To Debt Ratio0.06560.12470.0809
Slightly volatile
Price Sales Ratio10.025.03069.1751
Slightly volatile
Asset Turnover0.07650.12180.0943
Pretty Stable
Gross Profit Margin0.40.42310.8446
Slightly volatile
Price Fair Value1.531.17721.3969
Slightly volatile

Sabra Healthcare Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap3.5 B3.3 B2.1 B
Slightly volatile
Enterprise Value3.2 B5.7 B3.7 B
Slightly volatile

Sabra Fundamental Market Drivers

Forward Price Earnings8.7108
Cash And Short Term Investments46.7 M

Sabra Upcoming Events

20th of February 2024
Upcoming Quarterly Report
View
1st of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
20th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Sabra Healthcare Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Sabra Healthcare income statement, its balance sheet, and the statement of cash flows. Sabra Healthcare investors use historical funamental indicators, such as Sabra Healthcare's revenue or net income, to determine how well the company is positioned to perform in the future. Although Sabra Healthcare investors may use each financial statement separately, they are all related. The changes in Sabra Healthcare's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Sabra Healthcare's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Sabra Healthcare Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Sabra Healthcare. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Revenue655.8 M404.9 M
Cost Of Revenue378.3 M397.2 M
Stock Based Compensation To Revenue 0.01  0.01 
Sales General And Administrative To Revenue 0.07  0.11 
Research And Ddevelopement To Revenue 0.00  0.00 
Capex To Revenue 0.01  0.01 
Revenue Per Share 2.84  2.47 
Ebit Per Revenue 0.36  0.47 

Currently Active Assets on Macroaxis

When determining whether Sabra Healthcare REIT offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sabra Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sabra Healthcare Reit Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sabra Healthcare Reit Stock:
Check out the analysis of Sabra Healthcare Correlation against competitors.
You can also try the AI Investment Finder module to use AI to screen and filter profitable investment opportunities.

Complementary Tools for Sabra Stock analysis

When running Sabra Healthcare's price analysis, check to measure Sabra Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sabra Healthcare is operating at the current time. Most of Sabra Healthcare's value examination focuses on studying past and present price action to predict the probability of Sabra Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sabra Healthcare's price. Additionally, you may evaluate how the addition of Sabra Healthcare to your portfolios can decrease your overall portfolio volatility.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Is Sabra Healthcare's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sabra Healthcare. If investors know Sabra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sabra Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.286
Dividend Share
1.2
Earnings Share
0.06
Revenue Per Share
2.788
Quarterly Revenue Growth
0.933
The market value of Sabra Healthcare REIT is measured differently than its book value, which is the value of Sabra that is recorded on the company's balance sheet. Investors also form their own opinion of Sabra Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Sabra Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sabra Healthcare's market value can be influenced by many factors that don't directly affect Sabra Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sabra Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sabra Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sabra Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.